MindX Sciences Logo

News

A blood test may help the diagnosis and treatment of depression.  The Economist — May 3, 2021

MindX Sciences Aims to Bring Objectivity to Psychiatric Disorder Testing With RNA Expression Markers.  GenomeWeb — April 28, 2021

Panel of 26 Biomarkers May Allow for Precision Medicine Treatment Plans Among Patients With Mood Disorders.  PsychiatryAdvisor — April 26, 2021

Indianapolis, April 26, 2021 — MindX Sciences is proud to announce a partnership with Q2, a premier genomics lab.  View more...

Can a Blood Test Diagnose Depression?  HealthyWomen — April 20, 2021

Researchers develop blood test that could help gauge depression, bipolar disorder.  FOX5 New York — April 12, 2021

Bientôt un test sanguin pour détecter la dépression et le trouble bipolaire?  Pourqui Docteur — 11.04.2021

Researchers Develop Biomarker Blood Test for Depression, Bipolar Disorder.  Genetic Engineering & Biotechnology News — April 9, 2021

Indianapolis, IN, April 8th, 2021 — IU School of Medicine researchers develop blood test for depression, bipolar disorder.  View more...

Indianapolis, IN, March 9th, 2021 — Dr. Christopher Reist, an authority on PTSD and clinical trials, joined the Scientific Advisory Board (SAB) of MindX Sciences.

Indianapolis, IN, March 8th, 2021 — Dr. Alexander Niculescu gave a talk on “Precision Medicine for Mood Disorders”, an upcoming publication, at the annual invitation-only Translational Psychiatry meeting in Park City, Utah, this year held in a virtual format.

Indianapolis, IN, February 26th, 2021 — The United States Patent Office granted Patent Application No. 15/735,304 titled: PREDICTING SUICIDALITY USING A COMBINED GENOMIC AND CLINICAL RISK ASSESSMENT, licensed by MindX Sciences from Indiana University.

Can An Indy Startup Conquer Mental Health’s Final Frontier?  Indianapolis Monthly, March 2021